Understanding how these identified up- and downregulated genes respond to pharmacological Nrf2 activation holds the potential to unlock novel strategies for enhancing endogenous neuroprotective mechanisms in the hippocampus, ultimately leading to more effective therapies for stroke. The gene discussed is NFE2L2; the disease is Stroke.